To search for possible anti-tumor agents or anti-tumor promoters among natural or synthetic products, we used cyclic voltammetry to determine the reduction-oxidation potentials of heterocyclic quinones in phosphate buffer at pH 7.2. We determined the growth inhibitory-and cytotoxic activities of 12 heterocyclic quinone anti-tumor agent candidates against a panel of 39 human cancer cell lines (JFCR39). The average concentrations of the heterocyclic quinones required for 50% growth inhibition (GI 50 ) against JFCR39 ranged from 0.045 to 13.2 μM, and the 50% lethal concentration (LC 50 ) against JFCR39 ranged from 0.398 to 77.7 μM. The average values of GI 50 or LC 50 of the heterocyclic quinones correlated significantly with their reduction potentials. These results suggested that reduction-oxidation potentials could be a useful method for the discovery of novel antitumor agents.
Introduction
Naturally occurring quinones, which are widely distributed throughout both the animal and plant kingdoms, typically function as pigments and as intermediates in cellular respiration and photosynthesis. Several of these molecules possess anti-neoplastic chemotherapeutic properties [1, 2] . Quinones are found in many drugs, including anthracyclines, daunorubicin, doxorubicin, mitomycin, mitoxantrones, and saintopin, all of which are used in the clinical therapy of solid tumors. The cytotoxic effects of these quinones are primarily due to inhibition of DNA topoisomerase-II [3, 4] . Several recent publications have highlighted the anti-tumor activity of kigelinone (2-(1-hydroxyethyl)-5(or 8)-hydroxynaphtho [2,3-b] furan-4,9-dione), a furanonaphthoquinone molecule isolated from Tabebuia cassinoides [5] . Heterocyclic quinones containing nitrogen atoms possess excellent antitumor [6, 7] and other biologic activities [8, 9] . Previously, we reported the in vitro anti-tumor promoting activity of heterocyclic quinines, as evidenced by inhibitory effects on 12-Otetradecanoylphorbol-13-acetate (TPA)-induced Epstein-Barr virus early antigen (EBV-EA) activation in Raji cells [10, 11] . Standard redox potential is important in determining the physiological activity of drugs [12] . We employed cyclic voltammetry to determine the standard redox or first reduction potentials of anthraquinones, bianthraquinones, naphthoquinones, and azaanthraquinones at a physiological pH of 7.2. We found a significant correlation between the standard redox or first reduction potentials and the inhibitory effects (log IC 50 ) of these compounds on EBV-EA activation [13] [14] [15] [16] [17] [18] .
In this study, we have attempted to expand the potential use of reduction-oxidation potentials determined by cyclic voltammetry to the discovery of anti-tumor agents. We determined the growth inhibitory-and cytotoxic activities of 12 heterocyclic quinine anti-tumor agent candidates against a panel of 39 human cancer cell lines (JFCR39), an information-rich and pharmacologically well characterized drug discovery system [19] [20] [21] [22] [23] . Subsequently, we measured the reduction-oxidation potentials of these compounds in phosphate buffer at pH 7.2. Then, we examined the correlation between the activities (log GI 50 and log LC 50 ) and first reduction potentials of these compounds. Furthermore, we calculated additional molecular properties of heterocyclic quinones using the CAChe MOPAC program and the PM3 method [24] , and identified the partition coefficient (log P) and LUMO energy as useful parameters that could help predict anti-tumor activities of these compounds.
Results and Discussion
Twelve heterocyclic quinones ( Figure 1 ) were tested for their growth inhibitory-and cytotoxic activities against JFCR 39 cells; the results (the means of GI 50 and LC 50 values) are summarized in Table 1 . Compounds 2-4, 6-8, and 12 were cytotoxic (GI 50 : 0.045-0.831 μM). Compounds 7 and 8 exhibited the highest levels of cytotoxicity, with GI 50 values of 0.071 and 0.045 μM and LC 50 values of 0.724 and 0.398 μM, respectively. In contrast, compounds 9 and 11 were minimally cytotoxic, with GI 50 values of 13.18 and 9.33 μM, respectively. The presence of a phenolic hydroxy group increased the potency of compounds having similar backbone molecular structures (1→2,3); a similar tendency was observed for anthraquinones [18] . Replacement of the thiophene for a furan ring showed a similar tendency in activity (4 and 6, 7 and 8). The pyridine ring with the nitrogen in the 2 position lead to The graph ompounds (7 GI 50 and LC 5 gainst the lun MVI, the cen We performed multiple regression analyses for the log GI 50 and log LC 50 values using electronic and molecular properties of the heterocyclic quinone derivatives: log GI 50 = -6.097 -0.012 E pc-1 -2.338 LUMO (n = 12, r = 0.893) (7) log GI 50 = -9.864 -0.010 E pc-1 + 0.429 log P (n = 12, r = 0.869) (8) log LC 50 = -6.357 -0.013 E pc-1 -1.930 LUMO (n = 12, r = 0.911) (9) log GI 50 = -9.187 -0.011 E pc-1 + 0.428 log P (n = 12, r = 0.910) (10) Thus, E pc-1 , LUMO, and log P were promising parameters to predict GI 50 and LC 50 . It remains unclear, however, why these parameters correlate well with the GI 50 and LC 50 values of hererocyclic quinones. 
Experimental

Instruments, reagents and materials
List analytical instruments used-MS and NMR data are given. (12) were prepared by tandem-directed metalation reaction [26] . Benzo[g]quinoline-5,10-dione (9) was synthesized from 5,8-quinolone and cyclohexadiene derivatives [11] . Benzo[g]isoquinoline-5,10-dione (10) was synthesized from 5,8-isoquinolone and cyclohexadiene derivatives [27] . [3,2-b] 
Furano[2,3-g]isoquinoline-4,9-dione (8). HR-EI-MS
5-Methyl-4H-thieno
Cell lines and cell cultures
The panel of human cancer cell lines, described by Yamori et al. [19] [20] [21] [22] [23] , consists of the following 39 human cancer cell lines: lung cancer, NCI-H23, NCI-H226, NCI-H522, NCI-H460, A549, DMS273, and DMS114; colorectal cancer, HCC-2998, KM-12, HT-29, HCT-15, and HCT-116; gastric cancer, MKN-1, MKN-7, MKN-28, MKN-45, MKN-74 , and St-4; ovarian cancer, OVCAR-3, OVCAR-4, OVCAR-5, OVCAR-8, and SK-OV-3; breast cancer, BSY-1, HBC-4, HBC-5, MDA-MB-231, and MCF-7; renal cancer, RXF-631L and ACHN; melanoma, LOX-IMVI; glioma, U251, SF-268, SF-295, SF-539 , SNB-75, and SNB-78; and prostate cancer, DU-145 and PC-3. All cell lines were cultured at 37 ºC under 5% CO 2 in RPMI 1640 medium (Nissui Pharmaceutical, Tokyo, Japan) supplemented with 5% fetal bovine serum, penicillin (100 units/mL), and streptomycin (100 μg/mL).
Inhibition experiments were performed to assess the sensitivity of cells to various chemicals as described by Yamori et al. [19] . Growth inhibition was assessed using a sulforhodamine B (SRB) assay to determine the changes in total cellular protein after cancer cells were incubated for 48 h in the presence of test compounds [19, 28, 29] . Absorbances at 525 nm were measured in control wells (C) and test wells at time 0 (T 0 ) and at the indicated times thereafter (T) , 10 -7 , and 10 -8 M) and a negative control. All assays were performed in duplicate. Mean graphs, which show differential growth inhibition of each drug against the cell line panel, was generated based on calculations using a set of GI 50 values [29, 30] . To analyze correlations between the means of compounds A and B, we developed a COMPARE computer algorithm as described by Paull et al. [28] . Correlation coefficients were calculated according to the following formula: r = (Σ(x i -x m )(y i -y m ))/(Σ(x i -x m ) 2 Σ(y i -y m ) 2 ) 1/2 , in which x i and y i are log GI 50 values for compounds A and Bagainst each cell line and x m and y m are the mean values of x i and y i , respectively. We verified the accuracy of measured data by checking the dose response curves of reference control chemicals, such as mitomycin-C, paclitaxel, and SN-38, in every experiment.
Electrochemical measurements
Cyclic voltammetric measurements were performed on a conventional three-electrode system using a laboratory-constructed microcomputer-controlled system in which the working electrode potential was controlled by a potentiostat (Hokuto Denko, HA-301). Plastic-formed-carbon (PFC) electrodes with a surface area of 0.071 cm 2 (BAS, PFCE-3), Ag/AgCl (saturated NaCl) electrodes, and platinum coil electrodes were used as the working, reference, and counter electrodes, respectively. Before recording each voltammogram, the working electrode was pretreated as previously described [13] . Aliquots of 0.05 mM heterocyclic quinone solutions in 3:1 (v/v) 0.1 M phosphate buffer containing 0.1 M KCl (pH 7.2)-ethanol were degassed using purified N 2 gas prior to voltammetric measurements. The electrolytic cell was water-jacketed to maintain a constant temperature of 25 ± 0.1 ºC.
